Phospho-TH (Ser19) Antibody

What is the functional significance of tyrosine hydroxylase phosphorylation at Ser19?

Ser19 phosphorylation serves multiple regulatory functions in TH biology. Primarily, phosphorylated Ser19 (pSer19) provides a high-affinity binding site for 14-3-3 proteins, particularly YWHAG, creating a protein-protein interaction platform that influences subsequent regulatory events . This phosphorylation event, together with Ser62 phosphorylation, triggers the proteasomal degradation of TH through the ubiquitin-proteasome pathway .

Interestingly, while pSer19 does not directly increase TH enzymatic activity in situ, it exerts significant influence on other phosphorylation sites. Research demonstrates that pSer19 strongly stimulates Ser31 phosphorylation (4.6-fold) while inhibiting pSer31 dephosphorylation (3.4-fold) . This suggests that Ser19 phosphorylation acts as a "master regulator" that modulates the phosphorylation dynamics at other regulatory sites, ultimately affecting dopamine synthesis through indirect mechanisms.

How does Ser19 phosphorylation kinetics differ from other TH phosphorylation sites?

Phosphorylation dynamics vary significantly between TH regulatory sites:

Experimental evidence shows that treatment of either PC12 cells or AtT-20 cells with elevated potassium produces a transient increase in Ser19 phosphorylation (up to 0.7 mol of phosphate/mol of subunit) alongside a more gradual and sustained increase in Ser40 phosphorylation . Critically, increases in TH activity and DOPA accumulation parallel the temporal course of Ser40 phosphorylation, not Ser19 . This further emphasizes that Ser19's primary role is in modulating other phosphorylation events rather than directly influencing enzyme activity.

Which kinases are responsible for Ser19 phosphorylation and under what conditions?

Multiple kinases can phosphorylate TH at Ser19, with differential activation under various physiological and experimental conditions:

• Cyclin-dependent kinase 5 (Cdk5): Identified as a physiological substrate for TH Ser19 phosphorylation. In vitro experiments have confirmed Cdk5's ability to phosphorylate Ser19 using purified components .

• Calcium/calmodulin-dependent protein kinase II (CaMKII): Capable of phosphorylating TH at Ser19 in a calcium-dependent manner, particularly during neuronal depolarization .

• Other kinases: Several additional protein kinases with different site specificities have been implicated in Ser19 phosphorylation, though with varying degrees of experimental validation .

Conditions that promote Ser19 phosphorylation include neuronal depolarization (elevated potassium), phorbol ester treatment, and nerve growth factor stimulation . These conditions typically involve calcium signaling, which activates CaMKII and potentially other calcium-dependent pathways leading to Ser19 phosphorylation.

What are optimal sample preparation methods for preserving TH Ser19 phosphorylation?

Preserving phosphorylation status during sample preparation is critical for accurate analysis. The following protocol has been validated in multiple studies:

• Immediate fixation/extraction: Process samples immediately after collection to prevent phosphatase activity.

• Phosphatase inhibitors: Include phosphatase inhibitor cocktails in all buffers.

• Acid precipitation method:

  • Collect and chill samples on ice

  • Centrifuge at 13,000 × g for 10 minutes

  • Rinse and resuspend in 0.5 mL deionized water

  • Re-pellet by centrifugation at 13,000 × g for 10 minutes

  • Solubilize protein pellets in sample buffer containing 0.1M Tris, 2% SDS, 1% glycerol, 0.1% bromophenol blue, and 100 mM DTT

  • Boil for 10 minutes

• Special considerations for phospho-epitopes: For effective separation of phosphorylated TH, consider using Phos-tag SDS-PAGE, which enables clear separation of unphosphorylated and phosphorylated forms .

This methodology ensures maximal retention of phosphorylation state while providing efficient protein extraction for subsequent analysis.

What controls should be included when using Phospho-TH (Ser19) antibodies?

Rigorous experimental design requires appropriate controls to validate antibody specificity and ensure reliable results:

Additionally, for immunohistochemistry and immunofluorescence applications, include tissue from TH-knockout animals or areas known to lack TH expression as negative controls. Triple immunolabeling for α-Syn, Total-TH, and TH PSer19 has proven valuable for assessing specificity and co-localization, particularly in neurodegeneration models .

How do different application methods compare for detecting Phospho-TH (Ser19)?

Each detection method offers distinct advantages and limitations:

For Western blot applications, 15% SDS-polyacrylamide gels are recommended for optimal separation of TH (59-60 kDa) . Transfer onto PVDF membrane generally provides better retention of phosphoproteins compared to nitrocellulose. For all applications, blocking with 5% nonfat milk in TBS-T (TBS + 0.05% Tween) for 1 hour at room temperature followed by primary antibody incubation overnight at 4°C yields optimal results .

How should researchers interpret discrepancies between total TH and Phospho-TH (Ser19) detection?

Discrepancies between total TH and pSer19 TH immunoreactivity are common and may reflect important biological phenomena rather than technical artifacts. Several mechanisms may explain these observations:

• Conformational masking: Phosphorylation can induce structural changes that mask epitopes recognized by Total-TH antibodies while maintaining accessibility of the phospho-epitope.

• Differential solubility: Research has demonstrated that phosphorylated forms of TH may exhibit different solubility properties, affecting extraction efficiency during sample preparation .

• Aggregation effects: In α-synuclein-associated conditions, significant inverse correlation between Total-TH immunoreactivity and α-Syn immunoreactivity has been observed, while a positive correlation exists between α-Syn immunoreactivity and TH PSer19 immunoreactivity (N = 85 cells, P < 0.0001) . This suggests that protein aggregation specifically affects the phosphorylation state of TH and its detection.

• Degradation dynamics: Since phosphorylation at Ser19 triggers proteasomal degradation , transient increases in pSer19 levels may precede decreases in total TH levels.

When analyzing such discrepancies, quantify both signal intensities and calculate the ratio of Phospho-TH (Ser19) to Total-TH immunoreactivity to normalize for changes in total protein expression. Consider using multiple antibodies targeting different total TH epitopes to verify findings.

What factors influence the detection sensitivity of Phospho-TH (Ser19)?

Multiple factors can affect detection sensitivity:

• Stoichiometry of phosphorylation: Under physiological conditions, only a fraction of total TH is phosphorylated at Ser19, typically reaching up to 0.7 mol of phosphate/mol of subunit even after stimulation .

• Antibody characteristics: Different commercial antibodies exhibit varying detection limits and specificities. For example, the antibody AF3112 reported detection sensitivity for endogenous levels of TH protein only when phosphorylated at S19 .

• Protein-protein interactions: The binding of 14-3-3 proteins to pSer19 may partially mask the epitope, reducing antibody accessibility .

• Technical parameters:

  • Sample preparation method (acid precipitation vs. standard lysis)

  • Gel percentage and electrophoresis conditions

  • Transfer efficiency for Western blots

  • Signal amplification method (standard ECL vs. enhanced systems)

• Co-occurring modifications: Additional phosphorylation at Ser31 or Ser40 may influence the conformation around the pSer19 epitope .

To enhance detection sensitivity, consider using signal amplification systems such as chemiluminescent HRP substrate with extended exposure times and advanced imaging systems with high sensitivity (e.g., Fuji imaging system with Image Gauge software) .

How do disease states affect Phospho-TH (Ser19) levels and detection?

Neurodegenerative conditions, particularly those affecting dopaminergic systems, can significantly alter Phospho-TH (Ser19) patterns:

Research with α-synuclein aggregation models has revealed that when α-Syn becomes aggregated (confirmed by Thioflavin-S staining), Total-TH immunoreactivity is reduced but still perceptible, while PSer19 staining remains robust . Importantly, this effect appears specific to α-synuclein, as GFP aggregation does not reduce Total-TH immunoreactivity or increase PSer19 immunoreactivity .

When studying disease models, utilize triple labeling techniques (e.g., Thioflavin-S, α-Syn, and Total-TH) to distinguish between effects on phosphorylation versus protein expression or aggregation.

How does pSer19 TH interact with 14-3-3 proteins and what are the functional implications?

Phosphorylation at Ser19 creates a high-affinity binding site for 14-3-3 protein family members, establishing a complex regulatory mechanism:

• Binding specificity: pSer19 induces high-affinity binding specifically to the 14-3-3 protein YWHAG , though other 14-3-3 isoforms may also interact.

• Regulatory effects on other phosphorylation sites: The binding of 14-3-3ζ counteracts the stimulatory effect of pSer19 on phosphorylation at Ser31 while amplifying the inhibitory effect on pSer31 dephosphorylation . This demonstrates how 14-3-3 binding modulates the effects of pSer19 on other regulatory sites.

• Effects on Ser40 regulation: In contrast to Ser31, the impact of pSer19 on Ser40 dephosphorylation is moderate, but 14-3-3ζ binding inhibits dephosphorylation - an effect consistent across different homo- and heterodimeric 14-3-3 isoforms .

• Independence from other sites: Additional phosphorylation of Ser31 or Ser40 has minimal impact on the binding affinity of pSer19 TH to 14-3-3 proteins , suggesting that pSer19-14-3-3 binding is a primary regulatory event.

Mathematical modeling studies suggest that these interactions allow Ser19 and 14-3-3 proteins to function as modulators of TH phosphorylation in response to neuronal co-signaling events . This provides a mechanism for integrating multiple signaling inputs to fine-tune dopamine synthesis.

How can Phospho-TH (Ser19) antibodies be used to study multisite phosphorylation dynamics?

Phospho-TH (Ser19) antibodies enable sophisticated analyses of the interconnected phosphorylation events regulating TH:

• Sequential phosphorylation studies: Using phospho-specific antibodies for each site (Ser19, Ser31, Ser40) allows researchers to track the temporal sequence of phosphorylation events following various stimuli. For example, elevated potassium treatment produces a transient increase in Ser19 phosphorylation followed by a more gradual increase in Ser40 phosphorylation .

• Site-specific mutant analyses: Comparing wild-type TH with site-directed mutants (e.g., S19A) enables determination of how each site influences phosphorylation at other positions. Such studies revealed that pSer19 strongly stimulates Ser31 phosphorylation (4.6-fold) .

• Phosphatase susceptibility assessment: Phospho-antibodies can be used to monitor dephosphorylation rates at each site under various conditions. Research shows that pSer19 inhibits pSer31 dephosphorylation (3.4-fold) .

• In vitro reconstitution systems: Using purified recombinant TH and kinases, researchers can systematically examine how prior phosphorylation at one site affects subsequent modifications at other sites:

These approaches have revealed that TH phosphorylation involves complex regulatory mechanisms where each phosphorylation event influences subsequent modifications through conformational changes and protein-protein interactions .

What role does Phospho-TH (Ser19) play in neurodegeneration models?

Phospho-TH (Ser19) detection has provided critical insights into dopaminergic dysfunction in neurodegeneration models:

• α-Synuclein interaction: Studies in α-synuclein overexpressing models reveal significant alterations in TH phosphorylation patterns. When α-Syn becomes aggregated (confirmed by Thioflavin-S staining), immunoreactivity for Total-TH appears reduced in dopaminergic neurons, while TH PSer19 labeling remains robust .

• Quantitative alterations: Precise quantification of signal intensities shows a significant inverse correlation between Total-TH immunoreactivity and α-Syn immunoreactivity and a positive correlation between α-Syn immunoreactivity and TH PSer19 immunoreactivity (N = 85 cells, P < 0.0001) .

• Temporal progression: In α-synuclein transduction models, PSer19 levels become significantly higher compared to control tissues at early timepoints (3.5 and 7 days), before major changes in total TH are observed .

• Diagnostic potential: The differential detection of Total-TH versus Phospho-TH (Ser19) in diseased neurons suggests potential utility of phospho-specific antibodies for early detection of dopaminergic dysfunction before overt neuronal loss.

• Mechanistic implications: The preservation of PSer19 immunoreactivity despite reduced Total-TH detection suggests that α-synuclein aggregation may interfere with normal TH processing and turnover rather than completely eliminating the protein .

These findings highlight how Phospho-TH (Ser19) antibodies can reveal subtle changes in dopaminergic neuron function that might be missed by conventional total protein markers, potentially offering earlier detection of disease processes.

How can researchers validate the phospho-specificity of Phospho-TH (Ser19) antibodies?

Rigorous validation of phospho-specificity is essential for reliable results:

• Phosphatase treatment: Divide samples and treat half with lambda phosphatase (λPP). A true phospho-specific antibody will show signal reduction or elimination in treated samples.

• Phospho-blocking peptide competition: Pre-incubate the antibody with the phosphopeptide used as the immunogen (e.g., synthesized phosphopeptide derived from human Tyrosine Hydroxylase around the phosphorylation site of serine 19 with sequence A-V-SP-E-Q) . Signal elimination confirms specificity.

• Mutagenesis approach: Compare samples expressing wild-type TH versus TH with Ser19 substituted with alanine or leucine. Studies confirm that elevated potassium produced comparable increases in DOPA accumulation in AtT-20 cells expressing wild-type rTH and in cells where Ser19 phosphorylation had been eliminated (by substitution of Leu for Ser19) .

• Phospho-mimetic mutants: Test antibody reactivity with S19D or S19E phospho-mimetic mutants, which should not be recognized by a truly phospho-specific antibody.

• Phosphoamino acid analysis: For definitive confirmation, perform phosphoamino acid analysis following the protocols described in research literature .

• Cross-reactivity assessment: Test for cross-reactivity with other phosphorylated proteins, particularly those with similar phosphorylation motifs, to confirm target specificity.

Commercial antibodies typically undergo validation by manufacturers, but researchers should independently verify specificity in their experimental systems, as matrix effects can influence antibody performance.

What are common technical issues when using Phospho-TH (Ser19) antibodies and their solutions?

Several technical challenges may arise when working with Phospho-TH (Ser19) antibodies:

For Western blot applications specifically:

• Ensure complete transfer of proteins to the membrane by checking the gel post-transfer

• Consider using specialized approaches like Phos-tag SDS-PAGE for improved separation of phosphorylated species

• Optimize primary antibody concentration and incubation conditions (1:500-1:2000 dilution, overnight at 4°C)

• Use enhanced chemiluminescence detection systems with extended exposure times for low abundance phospho-proteins

For immunohistochemistry applications:

• Include antigen retrieval steps to expose phospho-epitopes

• Use tyramide signal amplification systems to enhance detection sensitivity

• Consider thinner tissue sections (5-8 μm) for improved antibody penetration

What quantitative approaches are recommended for Phospho-TH (Ser19) analysis?

Accurate quantification of Phospho-TH (Ser19) requires careful methodological considerations:

• Normalization strategies:

  • Normalize phospho-signal to total TH (pSer19-TH/Total-TH ratio)

  • Include multiple loading controls (β-actin, GAPDH, or other housekeeping proteins)

  • Consider using total protein staining methods (e.g., Ponceau S, SYPRO Ruby) as alternative normalization approaches

• Densitometric analysis:

  • Use established software packages (e.g., Image Gauge software for Fuji imaging systems)

  • Ensure analysis is performed within the linear range of detection

  • Subtract local background for each band individually

• Phosphorylation stoichiometry determination:

  • Gold standard: 32P incorporation assays with purified components

  • Alternative: Phos-tag SDS-PAGE to separate and quantify unphosphorylated, monophosphorylated, and multiphosphorylated forms

• Statistical considerations:

  • Use appropriate statistical tests for phosphorylation data (often non-parametric due to distribution characteristics)

  • Account for potential inter-gel variability when comparing samples across multiple blots

  • Consider time-course experiments to capture transient phosphorylation events

• Advanced quantitative approaches:

  • Mass spectrometry-based quantification for absolute stoichiometry determination

  • Mathematical modeling as described in research literature for interpreting complex phosphorylation dynamics